Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study

BACKGROUND: Research has shown that 20–30% of prisoners meet the diagnostic criteria for attention-deficit hyperactivity disorder (ADHD). Methylphenidate reduces ADHD symptoms, but effects in prisoners are uncertain because of comorbid mental health and substance use disorders. AIMS: To estimate the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Psychiatry
Auteurs principaux: Asherson, Philip J., Johansson, Lena, Holland, Rachel, Bedding, Megan, Forrester, Andrew, Giannulli, Laura, Ginsberg, Ylva, Howitt, Sheila, Kretzschmar, Imogen, Lawrie, Stephen M., Marsh, Craig, Kelly, Caroline, Mansfield, Megan, McCafferty, Clare, Khan, Khuram, Müller-Sedgwick, Ulrich, Strang, John, Williamson, Grace, Wilson, Lauren, Young, Susan, Landau, Sabine, Thomson, Lindsay D. G.
Format: Artigo
Langue:Inglês
Publié: Cambridge University Press 2023
Sujets:
Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613969/
https://ncbi.nlm.nih.gov/pubmed/35657651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjp.2022.77
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires